Join Now

Author Archives: admin

ARUP Wins Two of Six Prestigious Choosing Wisely Champion Awards

SALT LAKE CITY (September 21, 2021)—Andrew Fletcher, MD, medical director of Consultative Services at ARUP Laboratories, and ARUP’s Consultative Services team, led by Sandy Richman, are among six healthcare leaders and systems honored with 2021 Choosing Wisely Champion Awards from the American Society for Clinical Pathology (ASCP). Launched in 2016, the Choosing Wisely Champions Program […]

Posted in Policy News | Leave a comment

Xenter, Backcountry, and Sera Prognostics Add New Senior Executives

This week Xenter, Backcountry, and Sera Prognostics announced changes to their executive teams. Here’s the deets: Xenter Salt Lake City, Utah-based Xenter, Inc. (XenterMD.com) has announced a new President of Xenter Medical Technologies (formerly Xenter Hospital Technologies) business unit. Mark Turco, MD, is highly qualified, coming from Sirtex Medical where he served as Executive Vice […]

Posted in BioUtah News | Leave a comment

Intermountain Healthcare and SCL Health Announce Intent to Merge

Intermountain Healthcare and SCL Health, two leading nonprofit healthcare organizations, have signed a Letter of Intent to merge and create a model health system that provides high-quality, accessible, and affordable healthcare to more patients and communities in Utah, Idaho, Nevada, Colorado, Montana, and Kansas. Upon completion of the merger, the combined system will employ more […]

Posted in BioUtah News | Leave a comment

Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney disease (DKD). KidneyIntelX enables a shift in focus from care […]

Posted in BioUtah News | Leave a comment

PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board

Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.” […]

Posted in BioUtah News | Leave a comment

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests

The Saragene test kits approved by the CDSCO use the Company’s patented CoPrimer™ technology for the qualitative detection of these mosquito-borne viruses. According to the World Health Organization, the global incidence of dengue has grown dramatically in recent decades to become a leading cause of death in some Asian and Latin American countries, with 70% […]

Posted in Policy News | Leave a comment

Jackson Hospital Continues to Lead by Adding New Non-Invasive Ventilation (NIV) Products; ReddyPort™ Elbow and NIV Maintenance for Oral Care

ReddyPort, a medical technology company focused on bringing new non-invasive ventilation (NIV) products into market

Posted in BioUtah News | Leave a comment

ELITechGroup received the CE mark for Saliva on SARS-CoV-2 ELITe MGB® Kit

ELITechGroup is pleased to announce the CE mark for use of saliva on SARS-CoV-2 ELITe MGB® Kit.

Posted in BioUtah News | Leave a comment

Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its second quarter ended June 30, 2021 and provided an update on recent business performance and strategic transformation plans.

Posted in BioUtah News | Tagged | Leave a comment

Webinar: New Non-dilutive Funding Resource for BioUtah Members

BioUtah has contracted with G2G, Washington DC’s premier consulting firm for non-dilutive funding, to receive a detailed monthly report on the funding landscape.

Posted in BioUtah News, Funding | Leave a comment

Letter to Utah Congressional Delegation RE: H.R. 3, The Lower Drug Costs Now Act

Today, BioUtah, in conjunction with Centro Civico Mexicano, First Step House, International Cancer Advocacy Network, Mental Healthy FIT, Northern Utah Coalition, and Patel Family Investments, sent a letter to Utah’s congressional delegation expressing concern with the reintroduction of H.R. 3, The Lower Drug Costs Now Act. In the letter, the coalition states its concern about […]

Posted in Policy News | Leave a comment

Webinar: From Utah the U.K.—Why Companies Should Consider an IPO on the London Stock Exchange

The webinar presented the opportunity for Utah companies to raise capital through an offering on London Stock Exchanges AIM platform

Posted in Events | Leave a comment